111 related articles for article (PubMed ID: 37838340)
41. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
[TBL] [Abstract][Full Text] [Related]
42. Design, Synthesis and Structure-Activity Relationship Studies of Novel Survivin Inhibitors with Potent Anti-Proliferative Properties.
Xiao M; Wang J; Lin Z; Lu Y; Li Z; White SW; Miller DD; Li W
PLoS One; 2015; 10(6):e0129807. PubMed ID: 26070194
[TBL] [Abstract][Full Text] [Related]
43. Targeting DDX3X Helicase Activity with BA103 Shows Promising Therapeutic Effects in Preclinical Glioblastoma Models.
Brai A; Riva V; Clementi L; Falsitta L; Zamperini C; Sinigiani V; Festuccia C; Sabetta S; Aiello D; Roselli C; Garbelli A; Trivisani CI; Maccari L; Bugli F; Sanguinetti M; Calandro P; Chiariello M; Quaranta P; Botta L; Angelucci A; Maga G; Botta M
Cancers (Basel); 2021 Nov; 13(21):. PubMed ID: 34771731
[TBL] [Abstract][Full Text] [Related]
44. Screen Targeting Lung and Prostate Cancer Oncogene Identifies Novel Inhibitors of RGS17 and Problematic Chemical Substructures.
Bodle CR; Schamp JH; O'Brien JB; Hayes MP; Wu M; Doorn JA; Roman DL
SLAS Discov; 2018 Apr; 23(4):363-374. PubMed ID: 29351497
[TBL] [Abstract][Full Text] [Related]
45. Discovery of Allosteric Inhibitors Targeting the Spliceosomal RNA Helicase Brr2.
Iwatani-Yoshihara M; Ito M; Klein MG; Yamamoto T; Yonemori K; Tanaka T; Miwa M; Morishita D; Endo S; Tjhen R; Qin L; Nakanishi A; Maezaki H; Kawamoto T
J Med Chem; 2017 Jul; 60(13):5759-5771. PubMed ID: 28586220
[TBL] [Abstract][Full Text] [Related]
46. Discovery of small-molecule inhibitors of Bcl-2 through structure-based computer screening.
Enyedy IJ; Ling Y; Nacro K; Tomita Y; Wu X; Cao Y; Guo R; Li B; Zhu X; Huang Y; Long YQ; Roller PP; Yang D; Wang S
J Med Chem; 2001 Dec; 44(25):4313-24. PubMed ID: 11728179
[TBL] [Abstract][Full Text] [Related]
47. Discovery and optimization of potent broad-spectrum arenavirus inhibitors derived from benzimidazole.
Dai D; Burgeson JR; Gharaibeh DN; Moore AL; Larson RA; Cerruti NR; Amberg SM; Bolken TC; Hruby DE
Bioorg Med Chem Lett; 2013 Feb; 23(3):744-9. PubMed ID: 23265895
[TBL] [Abstract][Full Text] [Related]
48. Non-specific chemical inhibition of the Fanconi anemia pathway sensitizes cancer cells to cisplatin.
Jacquemont C; Simon JA; D'Andrea AD; Taniguchi T
Mol Cancer; 2012 Apr; 11():26. PubMed ID: 22537224
[TBL] [Abstract][Full Text] [Related]
49. DEAD-box RNA Helicase DDX3: Functional Properties and Development of DDX3 Inhibitors as Antiviral and Anticancer Drugs.
Kukhanova MK; Karpenko IL; Ivanov AV
Molecules; 2020 Feb; 25(4):. PubMed ID: 32102413
[TBL] [Abstract][Full Text] [Related]
50. miR-634 exhibits anti-tumor activities toward hepatocellular carcinoma via Rab1A and DHX33.
Zhang CZ; Cao Y; Fu J; Yun JP; Zhang MF
Mol Oncol; 2016 Dec; 10(10):1532-1541. PubMed ID: 27693040
[TBL] [Abstract][Full Text] [Related]
51. Targeting the Type II Secretion System: Development, Optimization, and Validation of a High-Throughput Screen for the Identification of Small Molecule Inhibitors.
Waack U; Johnson TL; Chedid K; Xi C; Simmons LA; Mobley HLT; Sandkvist M
Front Cell Infect Microbiol; 2017; 7():380. PubMed ID: 28894700
[TBL] [Abstract][Full Text] [Related]
52. Discovery of spiro[indole-3,2'-pyrrolidin]-2(1H)-one based inhibitors targeting Brr2, a core component of the U5 snRNP.
Ito M; Iwatani M; Yamamoto T; Tanaka T; Kawamoto T; Morishita D; Nakanishi A; Maezaki H
Bioorg Med Chem; 2017 Sep; 25(17):4753-4767. PubMed ID: 28751196
[TBL] [Abstract][Full Text] [Related]
53. Cinnamide derived pyrimidine-benzimidazole hybrids as tubulin inhibitors: Synthesis, in silico and cell growth inhibition studies.
Sana S; Reddy VG; Srinivasa Reddy T; Tokala R; Kumar R; Bhargava SK; Shankaraiah N
Bioorg Chem; 2021 May; 110():104765. PubMed ID: 33677248
[TBL] [Abstract][Full Text] [Related]
54. Virtual screening to enrich hit lists from high-throughput screening: a case study on small-molecule inhibitors of angiogenin.
Jenkins JL; Kao RY; Shapiro R
Proteins; 2003 Jan; 50(1):81-93. PubMed ID: 12471601
[TBL] [Abstract][Full Text] [Related]
55. Discovery of novel class of histone deacetylase inhibitors as potential anticancer agents.
El-Awady R; Saleh E; Hamoudi R; Ramadan WS; Mazitschek R; Nael MA; Elokely KM; Abou-Gharbia M; Childers WE; Srinivasulu V; Aloum L; Menon V; Al-Tel TH
Bioorg Med Chem; 2021 Jul; 42():116251. PubMed ID: 34116381
[TBL] [Abstract][Full Text] [Related]
56. Synthesis and SAR studies of 5-(pyridin-4-yl)-1,3,4-thiadiazol-2-amine derivatives as potent inhibitors of Bloom helicase.
Rosenthal AS; Dexheimer TS; Gileadi O; Nguyen GH; Chu WK; Hickson ID; Jadhav A; Simeonov A; Maloney DJ
Bioorg Med Chem Lett; 2013 Oct; 23(20):5660-6. PubMed ID: 24012121
[TBL] [Abstract][Full Text] [Related]
57. Design, Synthesis, and Characterization of 4-Aminoquinazolines as Potent Inhibitors of the G Protein-Coupled Receptor Kinase 6 (GRK6) for the Treatment of Multiple Myeloma.
Uehling DE; Joseph B; Chung KC; Zhang AX; Ler S; Prakesch MA; Poda G; Grouleff J; Aman A; Kiyota T; Leung-Hagesteijn C; Konda JD; Marcellus R; Griffin C; Subramaniam R; Abibi A; Strathdee CA; Isaac MB; Al-Awar R; Tiedemann RE
J Med Chem; 2021 Aug; 64(15):11129-11147. PubMed ID: 34291633
[TBL] [Abstract][Full Text] [Related]
58. A Novel Anti-Cancer Agent, 1-(3,5-Dimethoxyphenyl)-4-[(6-Fluoro-2-Methoxyquinoxalin-3-yl)Aminocarbonyl] Piperazine (RX-5902), Interferes With β-Catenin Function Through Y593 Phospho-p68 RNA Helicase.
Kost GC; Yang MY; Li L; Zhang Y; Liu CY; Kim DJ; Ahn CH; Lee YB; Liu ZR
J Cell Biochem; 2015 Aug; 116(8):1595-601. PubMed ID: 25649741
[TBL] [Abstract][Full Text] [Related]
59. Tandem application of ligand-based virtual screening and G4-OAS assay to identify novel G-quadruplex-targeting chemotypes.
Musumeci D; Amato J; Zizza P; Platella C; Cosconati S; Cingolani C; Biroccio A; Novellino E; Randazzo A; Giancola C; Pagano B; Montesarchio D
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1341-1352. PubMed ID: 28130159
[TBL] [Abstract][Full Text] [Related]
60. Small-molecule inhibitors of acetyltransferase p300 identified by high-throughput screening are potent anticancer agents.
Yang H; Pinello CE; Luo J; Li D; Wang Y; Zhao LY; Jahn SC; Saldanha SA; Chase P; Planck J; Geary KR; Ma H; Law BK; Roush WR; Hodder P; Liao D
Mol Cancer Ther; 2013 May; 12(5):610-20. PubMed ID: 23625935
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
